603 related articles for article (PubMed ID: 6137185)
1. Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors.
Whitehouse PJ; Wamsley JK; Zarbin MA; Price DL; Tourtellotte WW; Kuhar MJ
Ann Neurol; 1983 Jul; 14(1):8-16. PubMed ID: 6137185
[TBL] [Abstract][Full Text] [Related]
2. Reduced glycine receptor in the spinal cord in amyotrophic lateral sclerosis.
Hayashi H; Suga M; Satake M; Tsubaki T
Ann Neurol; 1981 Mar; 9(3):292-4. PubMed ID: 6261674
[TBL] [Abstract][Full Text] [Related]
3. Receptor alterations associated with spinal motoneuron degeneration in bovine Akabane disease.
Gundlach AL; Grabara CS; Johnston GA; Harper PA
Ann Neurol; 1990 May; 27(5):513-9. PubMed ID: 2163234
[TBL] [Abstract][Full Text] [Related]
4. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis.
Plaitakis A
Ann Neurol; 1990 Jul; 28(1):3-8. PubMed ID: 1973889
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons.
Mu X; He J; Anderson DW; Trojanowski JQ; Springer JE
Ann Neurol; 1996 Sep; 40(3):379-86. PubMed ID: 8797527
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic, opioid and glycine receptor binding sites localized in human spinal cord by in vitro autoradiography. Changes in amyotrophic lateral sclerosis.
Gillberg PG; Aquilonius SM
Acta Neurol Scand; 1985 Sep; 72(3):299-306. PubMed ID: 2998142
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
Calingasan NY; Chen J; Kiaei M; Beal MF
Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
[TBL] [Abstract][Full Text] [Related]
8. [Immunocytochemical study of the spinal distribution of substance P, enkephalins, cholecystokinin and serotonin in amyotrophic lateral sclerosis].
Schoenen J; Reznik M; Delwaide PJ; Vanderhaeghen JJ
C R Seances Soc Biol Fil; 1985; 179(4):528-34. PubMed ID: 2421858
[TBL] [Abstract][Full Text] [Related]
9. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.
Rothstein JD
Clin Neurosci; 1995-1996; 3(6):348-59. PubMed ID: 9021256
[TBL] [Abstract][Full Text] [Related]
10. [Amyotrophic lateral sclerosis. Physiopathology and experimental models. Chemical neuroanatomy of the human spinal cord: applications to pathologic cases including amyotrophic lateral sclerosis].
Schoenen J
Rev Neurol (Paris); 1988; 144(11):664-71. PubMed ID: 3068777
[TBL] [Abstract][Full Text] [Related]
11. FAC1 expression and localization in motor neurons of developing, adult, and amyotrophic lateral sclerosis spinal cord.
Mu X; Springer JE; Bowser R
Exp Neurol; 1997 Jul; 146(1):17-24. PubMed ID: 9225734
[TBL] [Abstract][Full Text] [Related]
12. Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis.
Jiang YM; Yamamoto M; Tanaka F; Ishigaki S; Katsuno M; Adachi H; Niwa J; Doyu M; Yoshida M; Hashizume Y; Sobue G
J Neuropathol Exp Neurol; 2007 Jul; 66(7):617-27. PubMed ID: 17620987
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis.
Siklós L; Engelhardt J; Harati Y; Smith RG; Joó F; Appel SH
Ann Neurol; 1996 Feb; 39(2):203-16. PubMed ID: 8967752
[TBL] [Abstract][Full Text] [Related]
14. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
Whitehouse PJ; Trifiletti RR; Jones BE; Folstein S; Price DL; Snyder SH; Kuhar MJ
Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
Sen I; Nalini A; Joshi NB; Joshi PG
J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
[TBL] [Abstract][Full Text] [Related]
16. RNA content and volume of motor neurons in amyotrophic lateral sclerosis. I. The cervical swelling.
Davidson TJ; Hartmann HA; Johnson PC
J Neuropathol Exp Neurol; 1981 Jan; 40(1):32-6. PubMed ID: 6162920
[TBL] [Abstract][Full Text] [Related]
17. Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity.
Dentel C; Palamiuc L; Henriques A; Lannes B; Spreux-Varoquaux O; Gutknecht L; René F; Echaniz-Laguna A; Gonzalez de Aguilar JL; Lesch KP; Meininger V; Loeffler JP; Dupuis L
Brain; 2013 Feb; 136(Pt 2):483-93. PubMed ID: 23114367
[TBL] [Abstract][Full Text] [Related]
18. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis.
Martin LJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):613-22. PubMed ID: 11114260
[TBL] [Abstract][Full Text] [Related]
19. Alterations in neurotransmitter receptor binding in the spinal cord after transection.
Charlton G; Brennan MJ; Ford DM
Brain Res; 1981 Aug; 218(1-2):372-5. PubMed ID: 6268246
[No Abstract] [Full Text] [Related]
20. Immunohistochemical localization of vascular endothelial growth factor receptors-1, -2 and -3 in human spinal cord: altered expression in amyotrophic lateral sclerosis.
Spliet WG; Aronica E; Ramkema M; Witmer AN; Schlingemann RO; de Jong JM; Troost D
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):351-9. PubMed ID: 15305980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
